JMIR Research Protocols · 13 Nov 2026
Long-Term Mental Health and Functional Outcomes Among Adults Referred for Gender-Affirming Care: Protocol for a Longitudinal Mixed Methods Cohort Study (GLOW)
Magnus Nilssonh-index 5, Susanna Askelöf, Mark Kisch, Jonas Berge, Emma Claesdotter-Knutssonh-index 15
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Background Gender dysphoria is associated with impaired functioning, reduced quality of life, psychiatric symptoms, and increased health care needs. Although gender-affirming care is increasingly provided, studies of long-term outcomes remain insufficient, particularly studies using prospective designs integrating self-reported, clinical, registry-based, and qualitative data. Objective The Gender Longitudinal Outcomes and Well-being (GLOW) study aims to investigate long-term psychosocial, functional, and medical outcomes among adults referred for gender dysphoria assessment within the Swedish National Highly Specialized Care system. The primary aim is to estimate change in functional disability between the time of assessment completion and 24 months afterward. Secondary aims are to assess quality of life, gender congruence, psychiatric symptoms, substance use, self-concept clarity, personality functioning, health care use, work-related outcomes, mortality, and lived experiences of gender-affirming health care. Methods GLOW is a prospective longitudinal observational mixed methods cohort study embedded in the Swedish National Highly Specialized Care system for adult gender dysphoria. The target sample is approximately 500 adults. Patient-reported outcomes are collected at baseline, assessment completion, and 24 and 60 months after completion. The primary outcome is World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). Medical record and national registry data cover clinical exposures, health care use, medication, socioeconomic and work-related outcomes, and mortality. Semistructured interviews will be conducted with a purposive subsample of approximately 25 to 40 participants at either assessment completion or 24 months. Results The study was funded in 2025. Recruitment began in December 2025 at the Malmö clinic and in January 2026 at the Linköping clinic. As of September 2026, 174 participants had enrolled. Follow-up data collection is scheduled to continue through December 2030. Data analysis is expected to begin in spring 2027, with the first results expected to be published in autumn 2027. Conclusions By describing longitudinal trajectories and associations across self-report, clinical, registry, and qualitative data, the GLOW study is expected to strengthen the evidence base for adult gender dysphoria services. Because care pathways are not randomly assigned, comparisons between pathways will be interpreted as associations rather than causal treatment effects. Trial Registration ClinicalTrials.gov NCT07480590; https://clinicaltrials.gov/study/NCT07480590 International Registered Report Identifier (IRRID) DERR1-10.2196/101233
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Emma Claesdotter-Knutsson has the highest h-index among the authors (15).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (34)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 14 more references
A free account opens the rest of the citing papers and references on every paper’s page.